Brian Lenz
2022 - ADMA Biologics
In 2022, Brian Lenz earned a total compensation of $1.6M as Executive Vice President and Chief Financial Officer at ADMA Biologics, a 32% decrease compared to previous year.
Compensation breakdown
| Bonus | $471,755 |
|---|---|
| Option Awards | $288,321 |
| Salary | $445,578 |
| Stock Awards | $229,625 |
| Other | $165,785 |
| Total | $1,601,064 |
Lenz received $471.8K in bonus, accounting for 29% of the total pay in 2022.
Lenz also received $288.3K in option awards, $445.6K in salary, $229.6K in stock awards and $165.8K in other compensation.
Rankings
In 2022, Brian Lenz's compensation ranked 2,045th out of 5,387 executives tracked by ExecPay. In other words, Lenz earned more than 62.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,045 out of 5,387 | 62nd |
Division Manufacturing | 1,100 out of 2,922 | 62nd |
Major group Chemicals And Allied Products | 465 out of 1,304 | 64th |
Industry group Drugs | 425 out of 1,209 | 65th |
Industry Biological Products, Except Diagnostic Substances | 107 out of 280 | 62nd |
Source: SEC filing on April 13, 2023.
Lenz's colleagues
We found one more compensation record of an executive who worked with Brian Lenz at ADMA Biologics in 2022.
2022
Adam Grossman
ADMA Biologics
Chief Executive Officer
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019